HIV/AIDS Treatment Improving Worldwide
Just last year, it was announced that, for the first time in history, 50 percent of those infected with HIV/AIDS were receiving treatment. This landmark achievement is a massive process with different factors worldwide, but it’s all an interconnected humanitarian struggle against this life-threatening disease. As the year moves closer to 2019, it’s important to evaluate the measures being taken to keep the epidemic at bay and to take a closer look at the future of HIV/AIDS treatment worldwide.
A Survey of The World
The Joint United Nations Programme on HIV/AIDS, known as UNAIDS, reported in 2017 that, of the 36.7 million people living with HIV/AIDS, 19.5 million are now receiving life-saving treatment in the form of anti-retroviral drugs (ARVs).
This trend has risen steadily since 2014 when UNAIDS announced that, if countries could meet the following goals for 2030, the global HIV/AIDS epidemic would be eliminated. Some of these goals are:
- 90 percent of those with HIV are aware they carry the virus
- 90 percent of the previous group begins using ARVs for treatment
- 90 percent of those receiving treatment continue their treatment and reduce the levels of the virus in their system to levels below standard testing baselines.
These goals may seem as though it sets the bar high. However, after calculating the data from 168 countries in 2017, the world was already at 75-79-81. Several countries are doing exceedingly well: Iceland, Singapore, Sweden, Botswana, Cambodia, Denmark and the United Kingdom.
These nations have managed to keep the virus in 73 percent of the carrying population suppressed. This means that, after receiving HIV/AIDS treatment, 73 percent of individuals have such low levels of the virus in their blood that the disease is no longer transferable by them to another person.
An Uncertain Future
Though the world has made tremendous progress in recent years in controlling the number of HIV patients, much of this progress has to do with aid provided by the U.S. In 2018, the Trump Administration has been proposing cuts to the U.S. Emergency Plan for AIDS Relief (PEPFAR) program. As one of America’s major global health initiatives, PEPFAR is responsible for HIV/AIDS treatment to millions of patients around the world.
President Trump’s budget proposal would strip PEPFAR’s funding from $6 billion to $5 billion. This is significant, as this program benefits those living along east and southern Africa. This area contains the highest concentration of those living with HIV/AIDS worldwide. The $1 billion cut would result in 1.8 million deaths over the next ten years in South Africa and The Ivory Coast alone. Those currently receiving ARV treatment will not lose their access to the life-saving medications they need because of the budget cuts.
Though the outcome for the future is uncertain, currently the world has been succeeding in the fight against HIV/AIDS, and HIV/AIDS treatment is becoming a reality worldwide. If countries worldwide can stay on track in meeting UNAIDS guidelines, then the global community may see this notorious virus eliminated by 2030.